42055-15-2Relevant articles and documents
CYCLIN-DEPENDENT KINASE INHIBITORS
-
Page/Page column 231-232, (2020/07/15)
Described herein are compounds and their pharmaceutically acceptable salts, pharmaceutical compositions thereof, methods of treatment, and medical uses. The compounds described herein are modulators of cyclin-dependent kinases, and are useful in the treatment or alleviation of protein kinase associated disorders, including cancer, infectious diseases, autoimmune diseases, or cardiovascular diseases.
NOVEL INTERMEDIATES FOR CYCLOPENTADIENYL DERIVATIVES AND PREPARATION METHOD OF SAID CYCLOPENTADIENYL DERIVATIVES
-
Paragraph 0125; 0126; 0128; 0129, (2018/07/28)
The present invention relates to a novel cyclopentadienyl-ethyl-methylamine (CpEMA) oxalate of chemical formula 1, or cyclopentadienyl-propyl-methylamine (CpPMA) oxalate of chemical formula 2, which is an intermediate for preparing CpEMA of chemical formula 3, and CpPMA of chemical formula 4 forming a metal precursor used for a self-limiting reaction used for an atomic layer deposition (ALD) or chemical vapor deposition process, and to a method for preparing a compound of chemical formula 3 and a compound of chemical formula 4 by using the compound of chemical formula 1 or 2 as an intermediate. According to the present invention, provided is a method for conveniently and easily preparing, in a high purity, a cyclopentadienyl derivative forming a precursor used for a self-limiting reaction among precursors used for an ALD or chemical vapor deposition process by using a novel intermediate.COPYRIGHT KIPO 2018
Pyrazolo[3,4-c]pyridine derivative
-
Paragraph 0256; 0257; 0258, (2016/10/08)
The invention relates to a pyrazolo[3,4-c]pyridine derivative. The invention relates to a compound represented by a formula (I), a tautomer thereof, an optical isomer thereof or a pharmaceutically acceptable salt thereof, wherein the formula (I) is shown in the description, and Z, X, RNc, RNd, RNe and RNf are defined according to the claim 1. The invention further relates to the pharmaceutical composition contain the compound. The invention further relates to use of the compound or the pharmaceutical composition in preparing a drug for preventing and/or treating a disease which inhibits positive influence of an Xa factor, particularly use in preparing the drug for preventing and/or treating the disease which inhibits positive influence of the Xa factor under the condition of low hemorrhage risk.